Skip to content

Effect of moxibustion combined with low frequency electrical stimulation on gastrointestinal dysfunction in stroke patients: a randomized controlled trial.

Effect of moxibustion combined with low frequency electrical stimulation on gastrointestinal dysfunction in stroke patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003512
Enrollment
Unknown
Registered
2020-07-25
Start date
2020-09-23
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastrointestinal dysfunction in stroke patients

Interventions

Sponsors

Beijing Xiaotangshan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Patients with age between 30 and 80 years old, regardless of gender; (2) meet the diagnostic criteria of stroke and TCM stroke; (3) meet the above diagnosis of constipation; (4) the condition is stable after the onset of cerebral infarction or cerebral hemorrhage; (5) the consciousness is clear and the general condition is stable, and can cooperate with the treatment; (6) the patients and their families informed consent to accept the clinical trial, voluntarily participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) viscera effected in stroke; (2) patients with transient ischemic attack; (3) patients with previous organic lesions of colon and rectum; (4) patients with cerebral embolism caused by coronary heart disease, rheumatic heart disease, and other heart diseases combined with atrial fibrillation; (5) pregnant or lactating women; (6) Patients with severe hemorrhagic diseases; (7) unstable vital signs; (8) unable to adhere to treatment due to economic or distant reasons; (9) allergic or intolerant to moxa and electrical stimulation.

Design outcomes

Primary

MeasureTime frame
Constipation symptom scale;

Secondary

MeasureTime frame
Bristol stool form scale, BSFS;Plasma gastrin;vasoactive intestinal peptide;Plasma motilin;

Countries

China

Contacts

Public ContactSun Jie

Beijing Xiaotangshan Hospital

bingxuehaitun520@163.com+86 13488665637

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026